Initial Public Offering (IPO)

Congratulations to Jiangsu Guofu Hydrogen Energy Equipment Co., Ltd. (2582.HK) on its successful Listing on the Mainboard of HKSE on 15 November 2024
 
Jiangsu Guofu Hydrogen Energy Equipment Co., Ltd. (“Guofu Hydrogen”) is a leading hydrogen energy storage and transport equipment manufacturer in China. The company develop and manufacture hydrogen energy core equipment used in the entire industrial value chain of hydrogen energy, which consists of its production, storage, transportation, refueling and use. The company is strategically located in the Yangtze River Delta, with convenient access to the ports thereof, which have abundant supply chain resources. Leveraging the advantages in geographic location and benefitting from favorable policies in the global and China’s hydrogen energy industry and hydrogen energy core equipment industry, the company is dedicated to becoming the center of the global supply chain of hydrogen energy core equipment.
 
With regard to this listing application, AVISTA Group is honored to be engaged in providing expected credit loss and long-term assets impairment related valuation service.
 
Congratulations again to Jiangsu Guofu Hydrogen Energy Equipment Co., Ltd. (2582.HK) on its successful listing. The issue price is HKD 65.00 per share, and the amount of funds raised is HKD 39 million.
 
<img src="../../../../../uploads/Slide1_10700d19f1.png" width="500" />
<img src="../../../../../uploads/Image_59_d2e8c45eb7.jpeg" width="500" /> <img src="../../../../../uploads/Image_58_332aef49c3.jpeg" width="500" />

233852410_m_normal_none.png

Congratulations to Jiangsu Guofu Hydrogen Energy Equipment Co., Ltd. (2582.HK) on its Successful Listing

Congratulations to WeRide Inc. (WRD.US) on its successful Listing on NASDAQ on 25 October 2024
 
WeRide Inc. is a leading, commercial-stage, global company that develops autonomous driving technologies from Level 2 to Level 4. WeRide aims to develop safe and reliable driverless solutions to make mobility and transportation safer, more affordable, and accessible.
 
With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services on preferred stocks, esop, IPs.
 
Congratulations again to WeRide Inc. (WRD.US) on its successful listing. The issue price is USD 15.50 per share, and the amount of funds raised is USD 100 million.
 
<img src="../../../../../uploads/Slide1_5a78b67192.png" width="500" />

147600044_l_normal_none.png

Congratulations to WeRide Inc. (WRD.US) on its Successful Listing

Congratulations to Qiniu Limited (2567.HK) on its successful Listing on the Mainboard of HKSE on 16 October 2024
 
Qiniu Limited (“Qiniu”) provide audiovisual cloud service as the third largest audiovisual PaaS provider in China. Qiniu’s MPaaS platform has a primary focus on providing cloud services in connection with audiovisual content (primarily consisting of images, audio and video contents), encompassing object storage, content distribution, data processing and real-time interactive live streaming and covering the full cycle of audiovisual data collection, storage, processing, distribution and consumption.
 
With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services in relation to M&amp;A, financing transactions and equity incentives.
 
Congratulations again to Qiniu Limited (2567.HK) on its successful listing. The issue price is HKD 2.75 per share, and the amount of funds raised is HKD 439.3 million.
 
<img src="../../../../../uploads/b56623955a190f23f3c3d1071014ee8_fe0f4f2c57.jpg" width="500" /> <img src="../../../../../uploads/d63f8124c25484092be9d392e823e1f_545686c45d.jpg" width="500" />
<img src="../../../../../uploads/Slide1_ce23b90160.png" width="500" />

172286178_l_normal_none.png

Congratulations to Qiniu Limited (2567.HK) on its successful Listing on the Mainboard of HKSE on 16 October 2024

Congratulations to Zhejiang Taimei Medical Technology Co.,Ltd. (2576.HK) on its successful Listing on the Mainboard of HKSE on 8 October 2024
 
Zhejiang Taimei Medical Technology Co.,Ltd. (“Taimei”) is a digital solution provider focused on the pharmaceutical and medical device industry in China. The software is cloud-based, allowing users to access it from various devices at any time over the internet, without the need for software installation and maintenance on their devices. These cloud-based software covers critical use cases in the research and development and commercialization of innovative drugs and medical devices. In addition to software, Taimei also provide a range of digital services, primarily assisting customers with independent reading of medical images, achieving efficient site management organization resource distribution and execution, offering pharmacovigilance services and other services to support customers’ the research and development and commercialization activities.
 
With regard to this listing application, AVISTA Group is honoured to be engaged in providing valuation services in relation to employee stock plan, M&amp;A and financing transactions.
 
Congratulations again to Zhejiang Taimei Medical Technology Co.,Ltd. (2576.HK) on its successful listing. The issue price is HKD 13.00 per share, and the amount of funds raised is HKD 259.5 million.
 
<img src="../../../../../uploads/Slide1_8c317e565a.png" width="500" />

106411763_l_normal_none.png

Congratulations to Zhejiang Taimei Medical Technology Co.,Ltd. (2576.HK) on its Successful Listing

Carote Ltd (“Carote”) offer a wide range of kitchenware products to consumers. From essential pots and pans to well-designed tableware and beverage containers, Carote Ltd ’s offerings aim to meet the varied needs of different kitchen scenarios and enhance the culinary experience of customers. As of the Latest Practicable Date, Carote Ltd ’s product portfolio consisted of SKUs across different kitchenware categories, including cookware, kitchen utensils, drinkware, among others.
 
With regard to this listing application, AVISTA Group is honored to be engaged in providing restricted stock unit related valuation service.
 
Congratulations again to Carote Ltd (2549.HK) on its successful listing. The issue price is HKD 5.78 per share, and the amount of funds raised is HKD 75 million. <img src="../../../../../uploads/Slide1_636b4c9d9f.png" width="500" />

138107282_l_normal_none.png

Congratulations to Carote Ltd (2549.HK) on its successful Listing on the Mainboard of HKSE on 2 October 2024

Congratulations to TYK Medicines, Inc (2410.HK) on its successful listing on the Mainboard of HKSE on 20 August 2024.
 
TYK Medicines, Inc (“TYK”) is a clinical-stage biopharmaceutical company committed to the discovery, acquisition, development and commercialization of differentiated targeted therapies to address unmet medical needs in cancer treatment. Since TYK inception in 2017, TYK has built a pipeline with 11 drug candidates, including Core Product TY-9591, six clinical stage products, and four preclinical stage or early clinical development stage products.
 
With regard to this listing application, AVISTA Group is honoured to be engaged in providing valuation analysis in connection with the fair value of preferred shares, impairment test of intangible assets, fair value of RSU and property investment.
 
Congratulations again to TYK Medicines, Inc (2410.HK) on its successful listing. The issue price is HKD12.10 per share and the amount of funds raised is HKD579 million.
 
<img src="../../../../../uploads/Slide1_4b331588b7.png" width="500" />

149465876_l_normal_none.png

Congratulations to TYK Medicines, Inc (2410.HK) on its Successful Listing

YXT.COM Group Holding Limited  (“YXT.COM”), as a technology enterprise, provides clients with digital corporate learning solutions, including: Software SaaS services, content solution services, and digital corporate learning operation services. It is an innovative platform company in the field of corporate training.
 
With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services on financial instruments, financial assets.
 
Congratulations again to YXT.COM Group Holding Limited (YXT.US) on its successful listing. The issue price is USD 11.00 per share, and the amount of funds raised is USD 25 million.
 
<img src="../../../../../uploads/Slide1_7cba03d0e9.png" width="500" />